Can ictal-MEG obviate the need for phase II monitoring in people with drug-refractory epilepsy? A prospective observational study

Delineation of IOZ by ictal-MEG helped convert DRE patients unsuitable for surgery or planned for phase II monitoring into candidates suitable for surgery, even ECoG-guided resections, and resulted in favorable outcomes in those who were operated.